ORGS logo

Orgenesis (ORGS) EBIT

Annual EBIT

-$62.28 M
-$52.14 M-514.42%

31 December 2023

ORGS EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly EBIT

-$8.20 M
+$521.00 K+5.97%

30 September 2024

ORGS Quarterly EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM EBIT

-$32.45 M
-$5.48 M-20.33%

30 September 2024

ORGS TTM EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ORGS EBIT Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-514.4%-201.5%+42.2%
3 y3 years+34.8%+16.6%+50.0%
5 y5 years-314.8%-72.0%-27.6%

ORGS EBIT High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-514.4%+34.8%-3481.2%+73.1%-220.1%+50.0%
5 y5 years-514.4%+34.8%-9636.0%+84.4%-220.1%+66.0%
alltimeall time<-9999.0%+34.8%-1386.8%+84.4%<-9999.0%+66.0%

Orgenesis EBIT History

DateAnnualQuarterlyTTM
Sept 2024
-
-$8.20 M(-6.0%)
-$32.45 M(+20.3%)
June 2024
-
-$8.72 M(-5.1%)
-$26.97 M(-44.7%)
Mar 2024
-
-$9.19 M(+45.0%)
-$48.75 M(-21.7%)
Dec 2023
-$62.28 M(+514.4%)
-$6.34 M(+133.0%)
-$62.28 M(+10.9%)
Sept 2023
-
-$2.72 M(-91.1%)
-$56.17 M(+3.6%)
June 2023
-
-$30.50 M(+34.3%)
-$54.24 M(+87.2%)
Mar 2023
-
-$22.72 M(+9819.7%)
-$28.98 M(+185.9%)
Dec 2022
-$10.14 M(-40.4%)
-$229.00 K(-71.2%)
-$10.14 M(-31.1%)
Sept 2022
-
-$794.00 K(-84.9%)
-$14.72 M(-38.0%)
June 2022
-
-$5.24 M(+35.4%)
-$23.75 M(+13.3%)
Mar 2022
-
-$3.87 M(-19.5%)
-$20.96 M(+23.3%)
Dec 2021
-$17.01 M(-82.2%)
-$4.81 M(-51.1%)
-$17.01 M(-73.8%)
Sept 2021
-
-$9.83 M(+300.6%)
-$64.91 M(+0.8%)
June 2021
-
-$2.45 M(-2953.5%)
-$64.42 M(-27.4%)
Mar 2021
-
$86.00 K(-100.2%)
-$88.76 M(-7.0%)
Dec 2020
-$95.48 M(+327.8%)
-$52.72 M(+464.7%)
-$95.48 M(+104.5%)
Sept 2020
-
-$9.34 M(-65.2%)
-$46.69 M(+10.8%)
June 2020
-
-$26.79 M(+303.5%)
-$42.12 M(+108.4%)
Mar 2020
-
-$6.64 M(+69.2%)
-$20.21 M(-7.9%)
Dec 2019
-$22.32 M(+48.7%)
-$3.92 M(-17.7%)
-$21.94 M(-13.7%)
Sept 2019
-
-$4.77 M(-2.4%)
-$25.42 M(+13.3%)
June 2019
-
-$4.88 M(-41.7%)
-$22.45 M(+11.5%)
Mar 2019
-
-$8.37 M(+13.0%)
-$20.14 M(+32.8%)
Nov 2018
-$15.01 M(+20.7%)
-$7.41 M(+313.7%)
-$15.16 M(+66.2%)
Aug 2018
-
-$1.79 M(-30.5%)
-$9.13 M(-13.5%)
May 2018
-
-$2.58 M(-24.1%)
-$10.55 M(-0.7%)
Feb 2018
-
-$3.39 M(+148.1%)
-$10.62 M(-14.6%)
Nov 2017
-$12.44 M(+4.0%)
-$1.37 M(-57.5%)
-$12.44 M(-21.1%)
Aug 2017
-
-$3.22 M(+21.6%)
-$15.76 M(+1.8%)
May 2017
-
-$2.65 M(-49.2%)
-$15.48 M(-9.9%)
Feb 2017
-
-$5.21 M(+11.2%)
-$17.19 M(+44.7%)
Nov 2016
-$11.97 M
-$4.68 M(+59.3%)
-$11.88 M(+36.7%)
DateAnnualQuarterlyTTM
Aug 2016
-
-$2.94 M(-32.4%)
-$8.69 M(+19.3%)
May 2016
-
-$4.35 M(-4366.7%)
-$7.28 M(+87.2%)
Feb 2016
-
$102.00 K(-106.8%)
-$3.89 M(-16.6%)
Nov 2015
-$4.67 M(-3.1%)
-$1.49 M(-2.8%)
-$4.67 M(+84.1%)
Aug 2015
-
-$1.54 M(+59.9%)
-$2.53 M(-39.8%)
May 2015
-
-$961.00 K(+42.6%)
-$4.21 M(-12.0%)
Feb 2015
-
-$674.00 K(-205.8%)
-$4.78 M(-0.6%)
Nov 2014
-$4.81 M(-10.3%)
$637.30 K(-119.8%)
-$4.81 M(-33.2%)
Aug 2014
-
-$3.21 M(+109.0%)
-$7.20 M(+46.3%)
May 2014
-
-$1.54 M(+118.7%)
-$4.92 M(+0.7%)
Feb 2014
-
-$702.60 K(-59.9%)
-$4.89 M(-11.2%)
Nov 2013
-$5.37 M(+7.6%)
-$1.75 M(+88.0%)
-$5.51 M(+7.4%)
Aug 2013
-
-$932.20 K(-38.0%)
-$5.13 M(-15.7%)
May 2013
-
-$1.50 M(+13.9%)
-$6.08 M(+11.5%)
Feb 2013
-
-$1.32 M(-3.7%)
-$5.46 M(+9.4%)
Nov 2012
-$4.99 M(+6790.3%)
-$1.37 M(-27.4%)
-$4.99 M(+35.6%)
Aug 2012
-
-$1.89 M(+115.9%)
-$3.68 M(+105.2%)
May 2012
-
-$874.80 K(+2.5%)
-$1.79 M(+94.8%)
Feb 2012
-
-$853.80 K(+1279.3%)
-$920.70 K(+1173.4%)
Nov 2011
-$72.40 K(+241.5%)
-$61.90 K(+2192.6%)
-$72.30 K(+292.9%)
Aug 2011
-
-$2700.00(+17.4%)
-$18.40 K(-13.2%)
May 2011
-
-$2300.00(-57.4%)
-$21.20 K(-10.9%)
Feb 2011
-
-$5400.00(-32.5%)
-$23.80 K(+12.3%)
Nov 2010
-$21.20 K(-17.2%)
-$8000.00(+45.5%)
-$21.20 K(+15.8%)
Aug 2010
-
-$5500.00(+12.2%)
-$18.30 K(-30.2%)
May 2010
-
-$4900.00(+75.0%)
-$26.20 K(-2.2%)
Feb 2010
-
-$2800.00(-45.1%)
-$26.80 K(+4.3%)
Nov 2009
-$25.60 K(+631.4%)
-$5100.00(-61.9%)
-$25.70 K(+24.8%)
Aug 2009
-
-$13.40 K(+143.6%)
-$20.60 K(+186.1%)
May 2009
-
-$5500.00(+223.5%)
-$7200.00(+323.5%)
Feb 2009
-
-$1700.00
-$1700.00
Nov 2008
-$3500.00
-
-

FAQ

  • What is Orgenesis annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Orgenesis?
  • What is Orgenesis annual EBIT year-on-year change?
  • What is Orgenesis quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Orgenesis?
  • What is Orgenesis quarterly EBIT year-on-year change?
  • What is Orgenesis TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Orgenesis?
  • What is Orgenesis TTM EBIT year-on-year change?

What is Orgenesis annual earnings before interest & taxes?

The current annual EBIT of ORGS is -$62.28 M

What is the all time high annual EBIT for Orgenesis?

Orgenesis all-time high annual earnings before interest & taxes is -$3500.00

What is Orgenesis annual EBIT year-on-year change?

Over the past year, ORGS annual earnings before interest & taxes has changed by -$52.14 M (-514.42%)

What is Orgenesis quarterly earnings before interest & taxes?

The current quarterly EBIT of ORGS is -$8.20 M

What is the all time high quarterly EBIT for Orgenesis?

Orgenesis all-time high quarterly earnings before interest & taxes is $637.30 K

What is Orgenesis quarterly EBIT year-on-year change?

Over the past year, ORGS quarterly earnings before interest & taxes has changed by -$5.48 M (-201.51%)

What is Orgenesis TTM earnings before interest & taxes?

The current TTM EBIT of ORGS is -$32.45 M

What is the all time high TTM EBIT for Orgenesis?

Orgenesis all-time high TTM earnings before interest & taxes is -$1700.00

What is Orgenesis TTM EBIT year-on-year change?

Over the past year, ORGS TTM earnings before interest & taxes has changed by +$23.72 M (+42.23%)